What type of study is this?

This is a Systematic Review study.

September 16, 2025BiomedicinesOpen Access

Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis

View Full Paper

Ask AI

Bookmark

Authors

KFKarima FarragGoethe University Frankfurt AAA AksanJustus-Liebig-Universität Gießen MKMarina KorotkovaKarolinska University Hospital

Discussion

Member takes

Implication

This analysis reveals increased IRF5 expression correlating with inflammatory markers in ulcerative colitis, suggesting its role as a therapeutic target.

Key Points

IRF5 expression is significantly higher in ulcerative colitis patients, indicating its involvement in disease inflammation.
The study found a positive correlation between IRF5-positive cells and disease activity measured by calprotectin levels.
Systematic analysis of colon biopsies from 30 patients with ulcerative colitis demonstrated critical findings related to IRF5.
These findings highlight the potential of IRF5 as a biomarker for inflammatory bowel disease, necessitating further investigation.

Cite This Study

Farrag et al. (2025) studied this question.

synapsesocial.com/papers/68d454d131b076d99fa5a64d https://doi.org/10.3390/biomedicines13092251

View Full Paper

Ask AI

Bookmark

Implication

This analysis reveals increased IRF5 expression correlating with inflammatory markers in ulcerative colitis, suggesting its role as a therapeutic target.

Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis

Discussion

Member takes

Implication

Key Points

Cite This Study

Interferon Regulator Factor 5: A Novel Inflammatory Marker and Promising Therapeutic Target in Ulcerative Colitis

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider